Block Organ Transplant Purchases from China Act of 2025 (H.R.2114)
The bill was introduced in the House by Congressman Neal Dunn (R-FL) on March 4, 2025 (H.R.2114) alongside two original cosponsors, Rep. Gus Bilirakis (R-FL) and Rep. John Moolenaar (R-MI).
The purpose of the bill is to prohibit federal reimbursement for organ transplants and related medical services when the organ’s origins cannot be verified. It also imposes penalties on healthcare providers who knowingly engage in this behaviour.
Sponsors’ comments condemning atrocities against Uyghurs:
Congressman Neal Dunn:“Communist Party authorities regularly target Uyghurs and other ethnic and religious minorities in China for this barbaric practice.”
Congressman John Moolenaar: This bill is designed to prevent “any complicity in the trafficking of organs from innocent victims in China—many of whom are political prisoners, Uyghurs, and religious minorities.”
Congressman Gus Bilirakis: “There is overwhelming evidence that China has systematically targeted ethnic and religious minorities for forcibly acquired organ donation and that the country regularly violates internationally-accepted rules regarding organ donorship.”
The Block Organ Transplant Purchases from China Act:
- Amends Medicare and Medicaid statutes to deny coverage for organ transplants performed in China or using organs not procured through the U.S. Organ Procurement and Transplantation Network (OPTN). Related services are also excluded, unless needed to save a patient’s life post-transplant.
- Prohibits group and individual health plans from covering prohibited organ transplants or related services.
- Imposes criminal penalties of up to 2 years imprisonment and/or fines and civil penalties on healthcare providers who knowingly assist in prohibited transplants.
Visit the UHRP U.S. Legislation Tracker for other bills endorsed by the Uyghur Human Rights Project.